2型糖尿病患者における心血管疾患の発症に関する国際調査

基本情報

NCT ID

NCT03811288

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

7,548

治験依頼者名

Novo Nordisk A/S

概要

The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than prescribed to them by their doctor. Participants' participation will be one day/one visit at their doctor. The study will last for about 6 months in total.

対象疾患

介入

依頼者（Sponsor）